DISEASE SCANNER
Global Incurable Diseases Tracker
Migraine
A primary headache disorder characterized by recurrent attacks of moderate to severe throbbing pain, usually on one side of the head, often accompanied by nausea, vomiting, and sensitivity to light and sound. Can last 4-72 hours. Second most disabling condition worldwide.
1.0B
111
Symptoms
Treatment Options
Risk Factors
Diagnostic Methods
- 1Clinical diagnosis (ICHD-3 criteria)
- 2Headache history
- 3Physical/neurological exam
- 4Imaging (rule out secondary causes)
- 5Headache diary
Prognosis
Chronic condition with variable course. 30% improve with age (especially after menopause in women). 2-3% develop chronic migraine (>15 days/month). Quality of life significantly impacted.
Prevention
- Trigger identification and avoidance
- Regular sleep schedule
- Stress management
- Regular meals
- Hydration
- Aerobic exercise
- Preventive medications
Research Status
CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) revolutionizing prevention. CGRP receptor antagonists (ubrogepant, rimegepant) for acute treatment. Ditans (lasmiditan) for acute treatment. Neuromodulation devices (TMS, VNS) FDA-approved. Atogepant for prevention.
Affected Countries
Sources
- https://www.ncbi.nlm.nih.gov/books
- https://www.mayoclinic.org/diseases-conditions
- https://rarediseases.org/rare-diseases
Medical Disclaimer
This information is for educational purposes only. Always consult healthcare professionals for medical advice, diagnosis, and treatment.